A phase I study of PXL 770 in healthy volunteers

Trial Profile

A phase I study of PXL 770 in healthy volunteers

Recruiting
Phase of Trial: Phase I

Latest Information Update: 03 Apr 2017

At a glance

  • Drugs PXL 770 (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions; Proof of concept
  • Sponsors Poxel
  • Most Recent Events

    • 03 Apr 2017 According to a Poxel media release, company plans to initiate the multiple ascending dose portion of the Phase 1 study during the second half of 2017.
    • 27 Jan 2017 According to a Poxel media release, the company anticipates to continue the study during the second half of this year.
    • 27 Sep 2016 According to a Poxel media release, the second part of the phase 1b study is expected in 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top